News

WuXi AppTec Research Service Division and Cyclica announced a multi-phase collaboration to advance drug discovery programs by driving insights into small molecule polypharmacology,…
Read More...

Novocure and US Oncology Research are collaborating on PANOVA-3, a phase 3 pivotal trial testing the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in…
Read More...

Altasciences announced that it has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A. The transaction is expected to be completed at the end of…
Read More...

Agenus Inc, an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced that Merck, known as MSD outside…
Read More...

Onspira Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational product, OSP-101, for the treatment of…
Read More...

Inovio Pharmaceuticals, Inc. announced that the first participant has been dosed with PENNVAX-GP in a randomized clinical trial that will evaluate its ability to drive remission of HIV…
Read More...

Evotec AG announced that Haplogen GmbH, a Vienna-based biotechnology company and collaboration partner of Evotec, has entered into a multi-year drug discovery and development…
Read More...

Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease…
Read More...

LakePharma, the leading US-based biologics company specializing in antibody and protein engineering, cell line development, and protein production, announced that it has successfully…
Read More...

Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing a first-in-class platform of novel therapeutic compounds for the treatment of diseases…
Read More...

Biopharmaceutical company Emalex Biosciences (Emalex), the newest member of the Paragon Biosciences (Paragon) portfolio of companies, today announced it acquired Psyadon Pharmaceuticals…
Read More...

Izana Bioscience announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing spondylitis, a debilitating arthritic disease of the spine that…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair (omalizumab) for the prevention of severe allergic reactions…
Read More...

Global contract packaging organisation (CPO), Tjoapack has launched a new postponement packaging service to help customers address supply chain challenges including variable demand and…
Read More...

Cancer Prevention Pharmaceuticals announced the signing of a license agreement with Mallinckrodt Pharmaceuticals, through its Sucampo AG subsidiary, wherein Mallinckrodt obtained…
Read More...

Medicure Inc. announced that the United States Food and Drug Administration has approved its Abbreviated New Drug Application for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL)…
Read More...

TraceLink Inc., announced its Russia compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all…
Read More...

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel…
Read More...

Teneobio and Poseida Therapeutics announced a new research collaboration and licensing agreement to develop novel CAR-T therapies using Teneobio’s heavy chain only domain antibodies…
Read More...

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen, an SME focused on the development…
Read More...